NEW YORK, April 24 - Amersham Biosciences, which filed for an initial public offering as APBiotech in October 2000, withdrew its offering from the SEC yesterday, citing the company's recent acquisition by Amersham.
...and receive Daily News bulletins.
Already have an account?Login Now.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.
NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.
In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.